Enzon Pharmaceuticals Inc
ENZN
Market Cap$8.16M
Close$
Share Statistics
| Market cap | $8.16 Million |
|---|---|
| Enterprise Value | $-38,393,394.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.0 |
| Beta | 0.0 |
| Outstanding Shares | 74,214,603 |
| Avg 30 Day Volume | 42,763 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -33.87 |
|---|---|
| PEG | 55.05 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -1476.67 |
| Enterprise Value to EBIT | 36.95 |
| Enterprise Value to Net Income | 159 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Enzon Pharmaceuticals Inc
CEO: Andrew Rackear Enzon Pharmaceuticals, Inc is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the ...